NCT01938040

Brief Summary

This study is being done because the investigators wish to study ways to improve recovery after surgery. Injury, including surgical injury, causes inflammation. Inflammation is the body's attempt to protect itself and to start the healing process. Some surgical complications are related to the body's natural inflammatory response. Although mainly a healing response, inflammation can also have side effects which delay recovery. The investigators wish to determine the effect of a medication known as ibuprofen on recovery. You may know ibuprofen by the name Advil or Motrin. The medication will be given through the vein prior to the start of the surgery. Three blood samples will be taken, two while the patient is under anesthesia. The subject will be asked to complete several questionnaires.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started May 2013

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2013

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

May 24, 2013

Completed
4 months until next milestone

First Posted

Study publicly available on registry

September 10, 2013

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2014

Completed
2.4 years until next milestone

Results Posted

Study results publicly available

December 21, 2016

Completed
Last Updated

December 21, 2016

Status Verified

October 1, 2016

Enrollment Period

1.3 years

First QC Date

May 24, 2013

Results QC Date

September 23, 2015

Last Update Submit

October 28, 2016

Conditions

Keywords

laparoscopic cholecystectomy

Outcome Measures

Primary Outcomes (1)

  • Stress Response Inflammation Markers :Cortisol and C Reactive Protein (CRP)

    Serum concentration of cortisol, CRP, drawn in Post Anesthesia Care unit at 2 hours following surgery were compared with those same levels drawn preoperatively and intraoperatively.

    2 hours following end of surgery

Secondary Outcomes (6)

  • Immune Response IL-6

    2 hours postoperatively in PACU

  • Quality of Recovery-40

    preoperatively and -postoperative days 1 and 3

  • Modified Fatigue Severity Scale

    preoperative-postoperative day 1 and day 3

  • Immune Response:Serum Concentration of IL-10,

    2 hours post arrival in PACU

  • Cognitive Recovery.

    preoperatively- 2 hours in PACU, Post op day #1, post op day#3

  • +1 more secondary outcomes

Other Outcomes (1)

  • Cytokine Concentrations

    preoperative-intraoperative-postopoperative

Study Arms (2)

Ibuprofen

ACTIVE COMPARATOR

800mg administered IV in 100cc of normal saline over 5 minutes

Drug: ibuprofen

Sugar water

PLACEBO COMPARATOR

100mL of normal saline to be administered over 5 minutes

Other: sugar water/placebo

Interventions

single preoperative dose prior to surgery

Also known as: caldolor
Ibuprofen

single preoperative dose prior to surgery

Also known as: 100mL. intravenous sugar water administered over 5 minutes
Sugar water

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • undergoing laparoscopic cholecystectomy under general anesthesia
  • American Society of Anesthesiologists status of 1, 2 or 3 (as determined by the anesthesiologists)
  • not pregnant of breast feeding

You may not qualify if:

  • cognitively impaired
  • using antipsychotic drugs
  • chronic use of steroids or opioids
  • subject has received COX inhibitors within 3 days if surgery
  • subjects for whom opiates, benzodiazepines and COX inhibitors are contraindicated
  • subjects with a history of bleeding disorders or peptic ulcer disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

University Hospital

Newark, New Jersey, 07101, United States

Location

New York Methodist Hospital

Brooklyn, New York, 11215, United States

Location

New York University Hospital

New York, New York, 10016, United States

Location

MT. Sinai Medical Center

New York, New York, 10029, United States

Location

Related Publications (1)

  • Le V, Kurnutala L, SchianodiCola J, Ahmed K, Yarmush J, Daniel Eloy J, Shapiro M, Haile M, Bekker A. Premedication with Intravenous Ibuprofen Improves Recovery Characteristics and Stress Response in Adults Undergoing Laparoscopic Cholecystectomy: A Randomized Controlled Trial. Pain Med. 2016 Jun;17(6):1163-1173. doi: 10.1093/pm/pnv113. Epub 2016 Feb 18.

    PMID: 26893119BACKGROUND

MeSH Terms

Conditions

Gallbladder Diseases

Interventions

Ibuprofen

Condition Hierarchy (Ancestors)

Biliary Tract DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

PhenylpropionatesAcids, CarbocyclicCarboxylic AcidsOrganic Chemicals

Results Point of Contact

Title
Alex Bekker, MD, PhD
Organization
Rutgers/State University of New Jersey (NJMS)

Study Officials

  • Alex Bekker, MD, PhD

    Rutgers/NJMS

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 24, 2013

First Posted

September 10, 2013

Study Start

May 1, 2013

Primary Completion

August 1, 2014

Study Completion

August 1, 2014

Last Updated

December 21, 2016

Results First Posted

December 21, 2016

Record last verified: 2016-10

Data Sharing

IPD Sharing
Will not share

Locations